Published in J Virol on February 01, 2000
K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol (2002) 1.65
Human herpesvirus 8 envelope glycoprotein B mediates cell adhesion via its RGD sequence. J Virol (2003) 1.53
Array-based transcript profiling and limiting-dilution reverse transcription-PCR analysis identify additional latent genes in Kaposi's sarcoma-associated herpesvirus. J Virol (2010) 1.42
Activation of mitogen-activated protein kinase and NF-kappaB pathways by a Kaposi's sarcoma-associated herpesvirus K15 membrane protein. J Virol (2003) 1.30
Interaction of Epstein-Barr virus nuclear antigen leader protein (EBNA-LP) with HS1-associated protein X-1: implication of cytoplasmic function of EBNA-LP. J Virol (2000) 1.28
An Epstein-Barr-related herpesvirus from marmoset lymphomas. Proc Natl Acad Sci U S A (2001) 1.19
Unique structures in a tumor herpesvirus revealed by cryo-electron tomography and microscopy. J Struct Biol (2007) 0.96
Varicella-zoster virus infection of human fibroblast cells activates the c-Jun N-terminal kinase pathway. J Virol (2006) 0.96
Activation of Stat3 transcription factor by Herpesvirus saimiri STP-A oncoprotein. J Virol (2004) 0.93
Systematic mutagenesis of the murine gammaherpesvirus 68 M2 protein identifies domains important for chronic infection. J Virol (2008) 0.89
Equine herpesvirus protein E10 induces membrane recruitment and phosphorylation of its cellular homologue, bcl-10. J Cell Biol (2001) 0.86
Cryo-electron tomography of Kaposi's sarcoma-associated herpesvirus capsids reveals dynamic scaffolding structures essential to capsid assembly and maturation. J Struct Biol (2007) 0.86
The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity. J Virol (2000) 0.84
The Role of Gammaherpesviruses in Cancer Pathogenesis. Pathogens (2016) 0.83
Epstein-Barr Virus (EBV) Tegument Protein BGLF2 Promotes EBV Reactivation through Activation of the p38 Mitogen-Activated Protein Kinase. J Virol (2015) 0.83
Transcriptional regulation of the Kaposi's sarcoma-associated herpesvirus K15 gene. J Virol (2006) 0.83
Multi-transmembrane protein K15 of Kaposi's sarcoma-associated herpesvirus targets Lyn kinase in the membrane raft and induces NFAT/AP1 activities. Exp Mol Med (2008) 0.80
Evolutionary aspects of oncogenic herpesviruses. Mol Pathol (2000) 0.79
The A2 gene of alcelaphine herpesvirus-1 is a transcriptional regulator affecting cytotoxicity in virus-infected T cells but is not required for malignant catarrhal fever induction in rabbits. Virus Res (2014) 0.77
Model-based inference of recombination hotspots in a highly variable oncogene [corrected]. J Mol Evol (2004) 0.77
The Modulation of Apoptotic Pathways by Gammaherpesviruses. Front Microbiol (2016) 0.76
Measurement of γHV68 infection in mice. J Vis Exp (2011) 0.75
Condylomatous genital lesions in cynomolgus macaques from Mauritius. Toxicol Pathol (2012) 0.75
Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science (1994) 39.60
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med (1995) 21.16
Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood (1995) 16.81
VIRUS PARTICLES IN CULTURED LYMPHOBLASTS FROM BURKITT'S LYMPHOMA. Lancet (1964) 14.21
Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci U S A (1996) 12.89
An EBV membrane protein expressed in immortalized lymphocytes transforms established rodent cells. Cell (1985) 10.13
The TNF receptor 1-associated protein TRADD signals cell death and NF-kappa B activation. Cell (1995) 8.80
Detection of herpesvirus-like DNA sequences in Kaposi's sarcoma in patients with and without HIV infection. N Engl J Med (1995) 8.52
Kaposi's sarcoma-associated herpesvirus gene expression in endothelial (spindle) tumor cells. J Virol (1997) 6.61
Molecular mimicry of human cytokine and cytokine response pathway genes by KSHV. Science (1996) 6.57
TAP, the human homolog of Mex67p, mediates CTE-dependent RNA export from the nucleus. Mol Cell (1998) 5.85
G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature (1998) 5.24
Clonal proliferations of cells infected with Epstein-Barr virus in preinvasive lesions related to nasopharyngeal carcinoma. N Engl J Med (1995) 4.62
Epstein-Barr virus latent infection membrane protein alters the human B-lymphocyte phenotype: deletion of the amino terminus abolishes activity. J Virol (1988) 4.55
The X-linked lymphoproliferative-disease gene product SAP regulates signals induced through the co-receptor SLAM. Nature (1998) 4.47
Epstein-Barr virus nuclear proteins EBNA-3A and EBNA-3C are essential for B-lymphocyte growth transformation. J Virol (1993) 4.05
Cell-homologous genes in the Kaposi's sarcoma-associated rhadinovirus human herpesvirus 8: determinants of its pathogenicity? J Virol (1997) 3.88
Angiogenic and HIV-inhibitory functions of KSHV-encoded chemokines. Science (1997) 3.70
Influence of the Epstein-Barr virus nuclear antigen EBNA 2 on the growth phenotype of virus-transformed B cells. J Virol (1987) 3.53
Kaposi's sarcoma-associated herpesvirus contains G protein-coupled receptor and cyclin D homologs which are expressed in Kaposi's sarcoma and malignant lymphoma. J Virol (1996) 3.48
Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med (1997) 3.44
Transformation of Balb 3T3 cells by the BNLF-1 gene of Epstein-Barr virus. Oncogene (1988) 3.42
Association of TRAF1, TRAF2, and TRAF3 with an Epstein-Barr virus LMP1 domain important for B-lymphocyte transformation: role in NF-kappaB activation. Mol Cell Biol (1996) 3.22
Epstein-Barr virus-induced genes: first lymphocyte-specific G protein-coupled peptide receptors. J Virol (1993) 3.19
The Epstein-Barr virus LMP1 gene product induces A20 zinc finger protein expression by activating nuclear factor kappa B. J Biol Chem (1992) 3.13
Sequence and genomic analysis of a Rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J Virol (1999) 3.13
A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol (1997) 3.10
The Epstein-Barr virus latent membrane protein-1 (LMP1) mediates activation of NF-kappa B and cell surface phenotype via two effector regions in its carboxy-terminal cytoplasmic domain. Oncogene (1995) 3.07
Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor. EMBO J (1998) 3.01
Stable growth transformation of human T lymphocytes by herpesvirus saimiri. Proc Natl Acad Sci U S A (1992) 2.94
Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J Virol (1997) 2.91
The Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaB. Proc Natl Acad Sci U S A (1997) 2.90
Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule. EMBO J (1997) 2.87
EBNA-2 and EBNA-LP cooperate to cause G0 to G1 transition during immortalization of resting human B lymphocytes by Epstein-Barr virus. EMBO J (1994) 2.79
Transformation of primary human endothelial cells by Kaposi's sarcoma-associated herpesvirus. Nature (1998) 2.76
Integral membrane protein 2 of Epstein-Barr virus regulates reactivation from latency through dominant negative effects on protein-tyrosine kinases. Immunity (1995) 2.74
A Bcl-2 homolog encoded by Kaposi sarcoma-associated virus, human herpesvirus 8, inhibits apoptosis but does not heterodimerize with Bax or Bak. Proc Natl Acad Sci U S A (1997) 2.63
X-linked recessive progressive combined variable immunodeficiency (Duncan's disease). Lancet (1975) 2.57
Human herpesvirus 8 encodes a homolog of interleukin-6. J Virol (1997) 2.56
Nononcogenic deletion mutants of herpesvirus saimiri are defective for in vitro immortalization. J Virol (1986) 2.52
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49
The structure and coding organization of the genomic termini of Kaposi's sarcoma-associated herpesvirus. Virology (1997) 2.44
Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med (1998) 2.38
An integral membrane protein (LMP2) blocks reactivation of Epstein-Barr virus from latency following surface immunoglobulin crosslinking. Proc Natl Acad Sci U S A (1994) 2.38
Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8). J Gen Virol (1998) 2.34
Deletion mutants of herpesvirus saimiri define an open reading frame necessary for transformation. J Virol (1989) 2.29
Classification of herpesvirus saimiri into three groups based on extreme variation in a DNA region required for oncogenicity. J Virol (1984) 2.25
Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med (1989) 2.25
Activation of the cJun N-terminal kinase (JNK) pathway by the Epstein-Barr virus-encoded latent membrane protein 1 (LMP1). Oncogene (1998) 2.22
A region of the Herpesvirus saimiri genome required for oncogenicity. Science (1985) 2.22
Tumor necrosis factor receptor associated factor 2 is a mediator of NF-kappa B activation by latent infection membrane protein 1, the Epstein-Barr virus transforming protein. Proc Natl Acad Sci U S A (1996) 2.18
Identification of transforming genes of subgroup A and C strains of Herpesvirus saimiri. Proc Natl Acad Sci U S A (1991) 2.18
A complex translational program generates multiple novel proteins from the latently expressed kaposin (K12) locus of Kaposi's sarcoma-associated herpesvirus. J Virol (1999) 2.16
Delineation of the cis-acting element mediating EBNA-2 transactivation of latent infection membrane protein expression. J Virol (1991) 2.16
The primary sequence of rhesus monkey rhadinovirus isolate 26-95: sequence similarities to Kaposi's sarcoma-associated herpesvirus and rhesus monkey rhadinovirus isolate 17577. J Virol (2000) 2.15
Deletion of DNA sequence in a nononcogenic variant of Herpesvirus saimiri. J Virol (1984) 2.14
The immunoreceptor tyrosine-based activation motif of Epstein-Barr virus LMP2A is essential for blocking BCR-mediated signal transduction. Virology (1997) 2.03
Identification of kaposin (open reading frame K12) as a human herpesvirus 8 (Kaposi's sarcoma-associated herpesvirus) transforming gene. J Virol (1998) 2.02
Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expression. J Virol (1998) 2.02
Novel organizational features, captured cellular genes, and strain variability within the genome of KSHV/HHV8. J Natl Cancer Inst Monogr (1998) 2.01
The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation. Proc Natl Acad Sci U S A (1997) 1.98
Epstein-Barr virus latent membrane protein 2A blocks calcium mobilization in B lymphocytes. J Virol (1993) 1.94
Characterization of LMP-1's association with TRAF1, TRAF2, and TRAF3. J Virol (1997) 1.90
An Epstein-Barr virus protein associated with cell growth transformation interacts with a tyrosine kinase. J Virol (1991) 1.90
Construction of replication-competent Herpesvirus saimiri deletion mutants. J Virol (1984) 1.89
CD40-induced growth inhibition in epithelial cells is mimicked by Epstein-Barr Virus-encoded LMP1: involvement of TRAF3 as a common mediator. Oncogene (1996) 1.85
Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol (1998) 1.84
Herpesvirus saimiri strain variability. J Virol (1982) 1.80
Epstein-Barr virus-encoded latent membrane protein 1 activates the JNK pathway through its extreme C terminus via a mechanism involving TRADD and TRAF2. J Virol (1999) 1.76
An Epstein-Barr virus transformation-associated membrane protein interacts with src family tyrosine kinases. J Virol (1992) 1.74
Identification of interleukin-6 as an autocrine growth factor for Epstein-Barr virus-immortalized B cells. J Virol (1990) 1.74
Expression of a virus-derived cytokine, KSHV vIL-6, in HIV-seronegative Castleman's disease. Am J Pathol (1997) 1.72
Kaposi's sarcoma-associated herpesvirus. Adv Cancer Res (1998) 1.72
Cutting edge: human 2B4, an activating NK cell receptor, recruits the protein tyrosine phosphatase SHP-2 and the adaptor signaling protein SAP. J Immunol (1999) 1.70
Deletion of DNA encoding the first five transmembrane domains of Epstein-Barr virus latent membrane proteins 2A and 2B. J Virol (1993) 1.69
BCL-2 but not its Epstein-Barr virus-encoded homologue, BHRF1, is commonly expressed in posttransplantation lymphoproliferative disorders. Blood (1996) 1.69
Comparative analysis identifies conserved tumor necrosis factor receptor-associated factor 3 binding sites in the human and simian Epstein-Barr virus oncogene LMP1. J Virol (1996) 1.67
Induction of B cell hyperplasia in simian immunodeficiency virus-infected rhesus macaques with the simian homologue of Kaposi's sarcoma-associated herpesvirus. J Exp Med (1999) 1.67
Cytostatic effect of Epstein-Barr virus latent membrane protein-1 analyzed using tetracycline-regulated expression in B cell lines. Virology (1996) 1.66
Identification of a spliced gene from Kaposi's sarcoma-associated herpesvirus encoding a protein with similarities to latent membrane proteins 1 and 2A of Epstein-Barr virus. J Virol (1999) 1.66
Association of the viral oncoprotein STP-C488 with cellular ras. Mol Cell Biol (1995) 1.66
The product of the Herpesvirus saimiri open reading frame 1 (tip) interacts with T cell-specific kinase p56lck in transformed cells. J Biol Chem (1995) 1.65
Deregulated signal transduction by the K1 gene product of Kaposi's sarcoma-associated herpesvirus. Proc Natl Acad Sci U S A (1999) 1.57
Epstein-Barr virus transcription in nasopharyngeal carcinoma. J Virol (1983) 1.57
Herpesvirus saimiri DNA in tumor cells--deleted sequences and sequence rearrangements. J Virol (1981) 1.55
Epstein-Barr virus nuclear antigen (EBNA)3C is an immortalizing oncoprotein with similar properties to adenovirus E1A and papillomavirus E7. Oncogene (1996) 1.52
Periodic illness associated with Epstein-Barr virus infection. Clin Infect Dis (1996) 1.49
Kaposi's sarcoma-associated herpesvirus: a lymphotropic human herpesvirus associated with Kaposi's sarcoma, primary effusion lymphoma, and multicentric Castleman's disease. Semin Diagn Pathol (1997) 1.46
STP and Tip are essential for herpesvirus saimiri oncogenicity. J Virol (1998) 1.45
Immortalizing genes of Epstein-Barr virus. Adv Virus Res (1991) 1.45
The Mex67p-mediated nuclear mRNA export pathway is conserved from yeast to human. EMBO J (1999) 4.49
Transformation of hematopoietic cells by BCR/ABL requires activation of a PI-3k/Akt-dependent pathway. EMBO J (1997) 3.34
Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J Virol (2000) 3.30
A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J Virol (1997) 3.10
Identification of a nef allele that causes lymphocyte activation and acute disease in macaque monkeys. Cell (1995) 3.03
Purified maturation promoting factor phosphorylates pp60c-src at the sites phosphorylated during fibroblast mitosis. Cell (1989) 3.01
Kaposi's sarcoma-associated herpesvirus encodes a functional cyclin. J Virol (1997) 2.57
Inhibition of natural killer cell-mediated cytotoxicity by Kaposi's sarcoma-associated herpesvirus K5 protein. Immunity (2000) 2.53
A role for natural simian immunodeficiency virus and human immunodeficiency virus type 1 nef alleles in lymphocyte activation. J Virol (1997) 2.41
Deregulation of cell growth by the K1 gene of Kaposi's sarcoma-associated herpesvirus. Nat Med (1998) 2.38
Identification of an immunoreceptor tyrosine-based activation motif of K1 transforming protein of Kaposi's sarcoma-associated herpesvirus. Mol Cell Biol (1998) 1.84
A robust xenotransplantation model for acute myeloid leukemia. Leukemia (2009) 1.67
Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor. J Virol (1998) 1.62
Inhibition of p300 histone acetyltransferase by viral interferon regulatory factor. Mol Cell Biol (2000) 1.61
STP and Tip are essential for herpesvirus saimiri oncogenicity. J Virol (1998) 1.45
Src homology 2-containing protein tyrosine phosphatase-2 acts as a negative regulator for MUC5AC transcription via the inhibition of the ERK1/2 MAPK signalling pathway in the airway. Acta Physiol (Oxf) (2013) 1.45
Herpesvirus saimiri as a model for gammaherpesvirus oncogenesis. Semin Cancer Biol (1999) 1.44
Identification and characterization of Kaposi's sarcoma-associated herpesvirus K8.1 virion glycoprotein. J Virol (1999) 1.42
Identification of the novel K15 gene at the rightmost end of the Kaposi's sarcoma-associated herpesvirus genome. J Virol (2000) 1.37
Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol (1998) 1.37
Tap: a novel cellular protein that interacts with tip of herpesvirus saimiri and induces lymphocyte aggregation. Immunity (1997) 1.35
Purification and characterization of a glycine betaine binding protein from Escherichia coli. J Biol Chem (1987) 1.34
Structure of the horseradish peroxidase isozyme C genes. Eur J Biochem (1988) 1.31
Zeta chain of the T-cell receptor interacts with nef of simian immunodeficiency virus and human immunodeficiency virus type 2. J Virol (1998) 1.31
Identification of a chymotrypsin-like proteinase in human mast cells. J Immunol (1986) 1.29
Inhibition of p53 tumor suppressor by viral interferon regulatory factor. J Virol (2001) 1.24
Visualization of G protein-coupled receptor trafficking with the aid of the green fluorescent protein. Endocytosis and recycling of cholecystokinin receptor type A. J Biol Chem (1997) 1.23
Inhibition of intracellular transport of B cell antigen receptor complexes by Kaposi's sarcoma-associated herpesvirus K1. J Exp Med (2000) 1.18
Use of virion DNA as a cloning vector for the construction of mutant and recombinant herpesviruses. Proc Natl Acad Sci U S A (1996) 1.13
Expression of constitutively active Raf-1 in the mitochondria restores antiapoptotic and leukemogenic potential of a transformation-deficient BCR/ABL mutant. J Exp Med (1998) 1.13
Identification of the R1 oncogene and its protein product from the rhadinovirus of rhesus monkeys. J Virol (1999) 1.12
Promotion of cell cycle progression by basic helix-loop-helix E2A. Mol Cell Biol (2001) 1.08
Genetic variation of herpesvirus saimiri subgroup A transforming protein and its association with cellular src. J Virol (1997) 1.05
Role of cellular tumor necrosis factor receptor-associated factors in NF-kappaB activation and lymphocyte transformation by herpesvirus Saimiri STP. J Virol (1999) 1.05
Cardiovascular regulation during water immersion. Appl Human Sci (1999) 1.02
RT-PCR detection and identification of three species of cucumoviruses with a genus-specific single pair of primers. J Virol Methods (1999) 1.00
A role for herpesvirus saimiri orf14 in transformation and persistent infection. J Virol (1998) 0.99
Phenotypic and functional consequences of herpesvirus saimiri infection of human CD8+ cytotoxic T lymphocytes. J Virol (1993) 0.96
Carbohydrate-binding protein 35 (Mac-2), a laminin-binding lectin, forms functional dimers using cysteine 186. J Biol Chem (1991) 0.95
Molecular piracy of Kaposi's sarcoma associated herpesvirus. Cytokine Growth Factor Rev (2001) 0.94
Downregulation of autophagy by Bcl-2 promotes MCF7 breast cancer cell growth independent of its inhibition of apoptosis. Cell Death Differ (2010) 0.94
EGFP-containing vector system that facilitates stable and transient expression assays. Biotechniques (1997) 0.94
Blood serum fluoride levels with enflurane (Ethrane) and isoflurane (Forane) anaesthesia during and following major abdominal surgery. Can Anaesth Soc J (1973) 0.94
Effects of occupation, lifestyle and genetic polymorphisms of CYP1A1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-naphthol concentrations. Carcinogenesis (2001) 0.93
Activation of lymphocyte signaling by the R1 protein of rhesus monkey rhadinovirus. J Virol (2000) 0.92
Direct Blue 71 staining of proteins bound to blotting membranes. Electrophoresis (2000) 0.91
Desmoplastic small round cell tumor presenting in pleural fluid and accompanied by desmin-positive mesothelial cells. Acta Cytol (1995) 0.90
Decreased immunoglobulin deposition in tumors and increased immature B cells in p53-null mice. Cell Growth Differ (1997) 0.90
Structure of the CAC1 gene and in situ characterization of its expression. The Arabidopsis thaliana gene coding for the biotin-containing subunit of the plastidic acetyl-coenzyme A carboxylase. Plant Physiol (1997) 0.89
Immune evasion strategies of Kaposi's sarcoma-associated herpesvirus. Curr Top Microbiol Immunol (2002) 0.88
Enhanced downregulation of Lck-mediated signal transduction by a Y114 mutation of herpesvirus Saimiri tip. J Virol (1997) 0.88
Crystal structure of a viral cyclin, a positive regulator of cyclin-dependent kinase 6. Structure (1999) 0.88
Substitution of ras for the herpesvirus saimiri STP oncogene in lymphocyte transformation. J Virol (1998) 0.87
Comparative analysis of the transforming mechanisms of Epstein-Barr virus, Kaposi's sarcoma-associated herpesvirus, and Herpesvirus saimiri. Adv Cancer Res (2001) 0.87
C-terminal fragment of amyloid precursor protein induces astrocytosis. J Neurochem (2001) 0.87
Inhibition of human immunodeficiency virus-1 protease by a C2-symmetric phosphinate. Synthesis and crystallographic analysis. Biochemistry (1993) 0.86
Broad bean wilt virus Causes Necrotic Symptoms and Generates Defective RNAs in Capsicum annuum. Phytopathology (2000) 0.85
Increasing intracellular concentrations of thymosin beta 4 in PtK2 cells: effects on stress fibers, cytokinesis, and cell spreading. Cell Motil Cytoskeleton (1995) 0.85
Mutation of the Lck-binding motif of Tip enhances lymphoid cell activation by herpesvirus saimiri. J Virol (1998) 0.85
The collagen repeat sequence is a determinant of the degree of herpesvirus saimiri STP transforming activity. J Virol (2000) 0.84
Infection of soybean by cucumber mosaic virus as determined by viral movement protein. Arch Virol (2006) 0.83
Mutation of amino acids in pp60c-src that are phosphorylated by protein kinases C and A. Mol Cell Biol (1989) 0.82
Thermal balance of man in water: prediction of deep body temperature change. Appl Human Sci (1996) 0.81
Increase of heat loss by wearing gloves and boots in wet-suited subjects working in cold water. Ann Physiol Anthropol (1992) 0.81
Counterion-dye staining method for DNA in agarose gels using crystal violet and methyl orange. Electrophoresis (2001) 0.80
Osmotic regulation of PhoE porin synthesis in Escherichia coli. J Bacteriol (1990) 0.80
Effect of indomethacin phonophoresis on the relief of temporomandibular joint pain. Cranio (1997) 0.80
The complete genome sequence of pepper severe mosaic virus and comparison with other potyviruses. Arch Virol (2006) 0.79
Caudal epidural block in children: comparison of needle insertion parallel with caudal canal versus conventional two-step technique. Anaesth Intensive Care (2010) 0.79
Effect of dehydration on thirst and drinking during immersion in men. J Appl Physiol (1985) (1992) 0.79
Primate herpesviral oncogenes. Mol Cells (1999) 0.79
Efficacy of low-calorie, partial meal replacement diet plans on weight and abdominal fat in obese subjects with metabolic syndrome: a double-blind, randomised controlled trial of two diet plans - one high in protein and one nutritionally balanced. Int J Clin Pract (2009) 0.79
Abnormal T cell receptor signal transduction of CD4 Th cells in X-linked lymphoproliferative syndrome. J Immunol (2001) 0.79
Modular structural elements in the replication origin region of Tetrahymena rDNA. Nucleic Acids Res (1995) 0.78
Incorporation of [1-13C]oleate into cellular triglycerides in differentiating 3T3L1 cells. Lipids (1999) 0.78
Manipulation of apoptosis by herpes viruses (Kaposi's sarcoma pathogenesis). Prog Mol Subcell Biol (2004) 0.77
Detection of DNA using a visible dye, Nile blue, in electrophoresed gels. Anal Biochem (2000) 0.77
Generation of a murine single chain Fv (scFv) antibody specific for cucumber mosaic virus (CMV) using a phage display library. Mol Cells (2001) 0.77
Generating CTLs against the subdominant EBV LMP antigens by transient expression of an A20 inhibitor with EBV LMP proteins in human DCs. Gene Ther (2011) 0.76
Resistance to tobamoviruses in transgenic tobacco plants expressing the coat protein gene of pepper mild mottle virus (Korean isolate). Mol Cells (1997) 0.76
Detection of proteins on polyacrylamide gels using calconcarboxylic acid. Anal Biochem (1993) 0.76
Esterification of free fatty acids in adipocytes: a comparison between octanoate and oleate. Biochem J (2000) 0.76
Quantitative analysis of eotaxin and RANTES messenger RNA in nasal polyps: association of tissue and nasal eosinophils. Laryngoscope (2000) 0.76
Detection of proteins in polyacrylamide gels using eriochrome black T and rhodamine B. Anal Biochem (1998) 0.75
Expression of p50 C-terminal Src kinase (Csk) in mouse testis. Arch Androl (2004) 0.75
Increased expression of CaM kinase II alpha in the brains of scrapie-infected mice. Neurosci Lett (1999) 0.75
G-actin pool and actin messenger RNA during development of the apical processes of the retinal pigment epithelial cells of the chick. Dev Biol (1992) 0.75
Cloning of the 3'-terminal region encoding movement and coat proteins of a Korean isolate of odontoglossum ringspot virus. Arch Virol (1995) 0.75
High performance liquid chromatographic analysis of a new proton pump inhibitor KR60436 and its active metabolite O-demethyl-KR60436 in rat plasma samples using column-switching. Arch Pharm Res (2001) 0.75
Trichodinid ectoparasites (ciliphora: Peritrichida) of some marine fishes from coastal regions of the Yellow Sea and Bohai Sea. Syst Parasitol (2001) 0.75
2,2-Dimethyl-4,5-diaryl-3(2H)furanone derivatives as selective cyclo-oxygenase-2 inhibitors. Bioorg Med Chem Lett (2001) 0.75
Pharmacological studies on the new quinoline derivative 1-(2-methylphenyl)-4-[(3-hydroxypropyl) amino]-6-trifluoromethoxy-2,3-dihydropyrrolo[3,2-c] quinoline with potent anti-ulcer effect. Arzneimittelforschung (1998) 0.75